Bellevue Asset Management AG
Filed a 13F-NT notice for 2026-06-30: this manager's Section 13(f) holdings are reported by another manager, so it no longer files its own holdings. Figures shown are from its last 13F-HR.
Sector Allocation
- Healthcare65.7%$431,250
- Other28.9%$189,760
- Consumer Staples4.6%$30,426
- Financials0.7%$4,877
AUM History
13fpro.ai/research/fund/bellevue-asset-management-ag-1642343
Conviction and streaks
Stable · top 10 = 31.0%From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.
Largest positions — Q4 2015
- Celgene$26K
BIIB
$26KGILD
$24KAMGN
$20KREGN
$20KMDT
$20KILMN
$18KABT
$17K- Mylan$17K
BDX
$16KCAH
$15KUNH
$14KSYK
$13KTEVA
$12K- Express$11K
- Endo$10K
- Auris$10K
ZBH
$10K- Alexion$9K
CVS
$9K
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/bellevue-asset-management-ag-1642343
Bellevue Asset Management AG 13F holdings — Q4 2015
$656K portfolio (+7.0% QoQ) · 127 holdings · Q4 2015 13F · top 10 are 31% of the stock portfolio
- 1
Celgene Corporation - COM
$26.0K
4.0% of stocks
-5%This quarter—Since Q-end—HeldAIQuality—Est. buy— $25.7K
3.9% of stocks
+17%This quarter—Since Q-end4+ qtrsHeld$24.3K
3.7% of stocks
-5%This quarter—Since Q-end4+ qtrsHeld$20.0K
3.0% of stocks
+3%This quarter—Since Q-end4+ qtrsHeld$19.8K
3.0% of stocks
-6%This quarter—Since Q-end4+ qtrsHeld$19.7K
3.0% of stocks
-5%This quarter—Since Q-end4+ qtrsHeldAIQuality68.7#272Est. buyEstimated buy price is Pro: unlock with a free trialTrimmed 3 qtrs in a row$17.5K
2.7% of stocks
+4%This quarter—Since Q-end4+ qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialAdded 3 qtrs in a row$17.1K
2.6% of stocks
-18%This quarter—Since Q-end4+ qtrsHeld- 9
Mylan Inc. - COM
$17.0K
2.6% of stocks
+40%This quarter—Since Q-end—HeldAIQuality—Est. buy— $16.2K
2.5% of stocks
+14%This quarter—Since Q-end4+ qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialAdded 3 qtrs in a row
All holdings — Bellevue Asset Management AG (Q4 2015)
127 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.
| # | Company | Held | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | CARDINAL HEALTH INC | Consumer Staples | $15K | 2.3% | 171K | +114% | 4+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 12 | UNITEDHEALTH GROUP INC | Healthcare | $14K | 2.1% | 120K | — | 4+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 13 | STRYKER CORP | Healthcare | $13K | 2.0% | 141K | — | 4+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 14 | TEVA PHARMACEUTICAL INDUSTRIES LTDadr | Healthcare | $12K | 1.8% | 177K | +4% | 4+ qtrsAdded 3 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 15 | — | Express Scripts Holding Company - COM | — | $11K | 1.6% | 124K | -23% | — | — | 13F |
| 16 | — | Endo International PLC - SHS | — | $10K | 1.6% | 171K | +8% | — | — | 13F |
| 17 | — | Auris Medical Holding AG - COM | — | $10K | 1.6% | 2.17M | — | — | — | 13F |
| 18 | ZIMMER BIOMET HOLDINGS, INC. | Healthcare | $10K | 1.5% | 96K | — | 4+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 19 | — | Alexion Pharmaceuticals, Inc. - COM | — | $9K | 1.4% | 49K | — | — | — | 13F |
| 20 | CVS HEALTH Corp | Healthcare | $9K | 1.4% | 96K | +75% | 4+ qtrsAdded 3 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 21 | LIGAND PHARMACEUTICALS INC | Healthcare | $9K | 1.4% | 82K | -15% | 4+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 22 | INCYTE CORP | Healthcare | $9K | 1.3% | 79K | +3% | 4+ qtrsAdded 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 23 | IONIS PHARMACEUTICALS INC | Healthcare | $9K | 1.3% | 138K | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 24 | BOSTON SCIENTIFIC CORP | Healthcare | $8K | 1.3% | 460K | +15% | 4+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 25 | MCKESSON CORP | Consumer Staples | $8K | 1.3% | 43K | +5% | 4+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 26 | $JAZZ | Jazz Pharmaceuticals plc | Healthcare | $8K | 1.3% | 60K | +7% | |||
| 27 | $VRTX | VERTEX PHARMACEUTICALS INC / MA | Healthcare | $8K | 1.3% | 67K | -19% | |||
| 28 | — | St. Jude Medical, Inc. - COM | — | $8K | 1.1% | 122K | — | |||
| 29 | $CI | Cigna Group | Healthcare | $7K | 1.1% | 48K | -17% | |||
| 30 | $CNC | CENTENE CORP | Healthcare | $7K | 1.1% | 106K | +428% | |||
| 31 | $BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $7K | 1.0% | 65K | — | |||
| 32 | — | Insys Therapeutics, Inc. - COM NEW | — | $7K | 1.0% | 232K | +10% | |||
| 33 | $COR | Cencora, Inc. | Consumer Staples | $7K | 1.0% | 64K | +7% | |||
| 34 | $PRGO | PERRIGO Co plc | Healthcare | $6K | 1.0% | 44K | +10% | |||
| 35 | — | Shire PLC - SPONSORED ADR | — | $6K | 1.0% | 31K | -0.2% | |||
| 36 | $ISRG | INTUITIVE SURGICAL INC | Healthcare | $6K | 1.0% | 12K | -15% | |||
| 37 | $CHRS | Coherus Oncology, Inc. | Healthcare | $6K | 0.9% | 257K | +12% | |||
| 38 | — | Aetna Inc. - COM | — | $6K | 0.9% | 53K | — | |||
| 39 | $HALO | HALOZYME THERAPEUTICS, INC. | Healthcare | $6K | 0.8% | 318K | +29% | |||
| 40 | $EW | Edwards Lifesciences Corp | Healthcare | $5K | 0.8% | 69K | +55% | |||
| 41 | $HUM | HUMANA INC | Healthcare | $5K | 0.8% | 30K | — | |||
| 42 | — | Horizon Pharma plc - SHS | — | $5K | 0.8% | 245K | +11% | |||
| 43 | $ALKS | Alkermes plc. | Healthcare | $5K | 0.8% | 66K | +11% | |||
| 44 | $JNJ | JOHNSON & JOHNSON | Healthcare | $5K | 0.8% | 50K | — | |||
| 45 | — | C.R. Bard, Inc. - COM | — | $5K | 0.8% | 27K | +10% | |||
| 46 | — | Mallinckrodt public limited company - SHS | — | $5K | 0.8% | 68K | -15% | |||
| 47 | — | Intersect Ent, Inc. - COM | — | $5K | 0.8% | 225K | +13% | |||
| 48 | $EGBN | EAGLE BANCORP INC | Financials | $5K | 0.7% | 55K | New | |||
| 49 | $SUPN.R1356576 | SUPERNUS PHARMACEUTICALS, INC. | Healthcare | $5K | 0.7% | 355K | +11% | |||
| 50 | $CYH | COMMUNITY HEALTH SYSTEMS INC | Healthcare | $5K | 0.7% | 174K | +7% | |||
| 51 | — | Achillion Pharmaceuticals, Inc. - COM | — | $5K | 0.7% | 420K | — | |||
| 52 | — | Lannett Inc. - COM | — | $4K | 0.7% | 107K | New | |||
| 53 | $BAX | BAXTER INTERNATIONAL INC | Healthcare | $4K | 0.6% | 110K | +120% | |||
| 54 | $ELV | Elevance Health, Inc. | Healthcare | $4K | 0.6% | 30K | — | |||
| 55 | $BMY | BRISTOL MYERS SQUIBB CO | Healthcare | $4K | 0.6% | 60K | — | |||
| 56 | $HCA | HCA Healthcare, Inc. | Healthcare | $4K | 0.6% | 60K | +50% | |||
| 57 | $NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | $4K | 0.6% | 65K | — | |||
| 58 | $NKTR | NEKTAR THERAPEUTICS | Healthcare | $4K | 0.6% | 216K | -10% | |||
| 59 | — | Cerner Corporation - COM | — | $4K | 0.6% | 60K | +9% | |||
| 60 | $PFE | PFIZER INC | Healthcare | $4K | 0.5% | 110K | +29% | |||
| 61 | $AGIO | AGIOS PHARMACEUTICALS, INC. | Healthcare | $4K | 0.5% | 54K | — | |||
| 62 | — | Novadaq Technologies Inc. - COM | — | $3K | 0.5% | 250K | — | |||
| 63 | $MRK | Merck & Co., Inc. | Healthcare | $3K | 0.5% | 60K | — | |||
| 64 | $HOLX | HOLOGIC INC | Healthcare | $3K | 0.5% | 81K | — | |||
| 65 | $MASI | MASIMO CORP | Healthcare | $3K | 0.5% | 75K | — | |||
| 66 | — | ARIAD Pharmaceuticals, Inc. - COM | — | $3K | 0.5% | 495K | — | |||
| 67 | — | Seattle Genetics, Inc. - COM | — | $3K | 0.5% | 68K | +42% | |||
| 68 | — | Medivation, Inc. - COM | — | $3K | 0.5% | 63K | +20% | |||
| 69 | — | Varian Medical Systems, Inc. - COM | — | $3K | 0.5% | 37K | — | |||
| 70 | $LLY | ELI LILLY & Co | Healthcare | $3K | 0.5% | 35K | — | |||
| 71 | $TMO | THERMO FISHER SCIENTIFIC INC. | Healthcare | $3K | 0.4% | 20K | — | |||
| 72 | $NVAX | NOVAVAX INC | Healthcare | $3K | 0.4% | 325K | — | |||
| 73 | $MGNX | MACROGENICS INC | Healthcare | $3K | 0.4% | 83K | — | |||
| 74 | $QGEN | QIAGEN N.V. | Healthcare | $3K | 0.4% | 92K | +14% | |||
| 75 | $CLDX | Celldex Therapeutics, Inc. | Healthcare | $3K | 0.4% | 160K | — | |||
| 76 | $COO | COOPER COMPANIES, INC. | Healthcare | $2K | 0.4% | 19K | — | |||
| 77 | — | Radius Health Inc. - COM NEW | — | $2K | 0.4% | 40K | New | |||
| 78 | $GMED | GLOBUS MEDICAL INC | Healthcare | $2K | 0.4% | 88K | — | |||
| 79 | $TFX | TELEFLEX INC | Healthcare | $2K | 0.4% | 19K | — | |||
| 80 | — | Nuvasive, Inc. - COM | — | $2K | 0.4% | 45K | — | |||
| 81 | $HCSG | HEALTHCARE SERVICES GROUP INC | Healthcare | $2K | 0.3% | 65K | — | |||
| 82 | $ALNY | ALNYLAM PHARMACEUTICALS, INC. | Healthcare | $2K | 0.3% | 24K | -25% | |||
| 83 | — | Zeltiq Aesthetics Inc. - COM | — | $2K | 0.3% | 75K | New | |||
| 84 | — | Prothena Corporation plc - SHS | — | $2K | 0.3% | 31K | +107% | |||
| 85 | — | Intercept Pharmaceuticals, Inc. - COM | — | $2K | 0.3% | 14K | +55% | |||
| 86 | — | Bluebird Bio, Inc. - COM | — | $2K | 0.3% | 29K | +41% | |||
| 87 | — | Clovis Oncology, Inc. - COM | — | $2K | 0.3% | 53K | -5% | |||
| 88 | — | Stericycle, Inc. - COM | — | $2K | 0.3% | 15K | -25% | |||
| 89 | $PTCT | PTC THERAPEUTICS, INC. | Healthcare | $2K | 0.3% | 55K | New | |||
| 90 | $INO | INOVIO PHARMACEUTICALS, INC. | Healthcare | $2K | 0.3% | 265K | — | |||
| 91 | — | Wright Medical Group Inc. - ORD SHS 0.03 PAR | — | $2K | 0.3% | 70K | New | |||
| 92 | — | Juno Therapeutics, Inc. - COM | — | $2K | 0.3% | 37K | +12% | |||
| 93 | $ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | $2K | 0.2% | 45K | -24% | |||
| 94 | — | WellCare Health Plans, Inc. - COM | — | $2K | 0.2% | 20K | — | |||
| 95 | $UTHR | UNITED THERAPEUTICS Corp | Healthcare | $1K | 0.2% | 9,300 | — | |||
| 96 | $DVA | DAVITA INC. | Healthcare | $1K | 0.2% | 20K | — | |||
| 97 | — | Infinity Pharmaceuticals, Inc. - COM | — | $1K | 0.2% | 160K | +23% | |||
| 98 | $LH | LABCORP HOLDINGS INC. | Healthcare | $1K | 0.2% | 10K | — | |||
| 99 | $ANGO | ANGIODYNAMICS INC | Healthcare | $1K | 0.2% | 100K | — | |||
| 100 | $RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | $1K | 0.2% | 10K | New | |||
| 101 | — | Alder Biopharmaceuticals Inc. - COM | — | $1K | 0.2% | 33K | -23% | |||
| 102 | $EXEL | EXELIXIS, INC. | Healthcare | $959 | 0.1% | 170K | +13% | |||
| 103 | $ESPR | Esperion Therapeutics, Inc. | Healthcare | $890 | 0.1% | 40K | — | |||
| 104 | $ABBV | AbbVie Inc. | Healthcare | $889 | 0.1% | 15K | -44% | |||
| 105 | — | Kite Pharma, Inc. - COM | — | $863 | 0.1% | 14K | -88% | |||
| 106 | — | Ishares TR - NASDQ BIOTEC ETF | — | $846 | 0.1% | 2,500 | — | |||
| 107 | — | Affymetrix, Inc. - COM | — | $807 | 0.1% | 80K | — | |||
| 108 | $RMD | RESMED INC | Healthcare | $805 | 0.1% | 15K | — | |||
| 109 | $PODD | INSULET CORP | Healthcare | $794 | 0.1% | 21K | -7% | |||
| 110 | — | Impax Laboratories, Inc. - COM | — | $770 | 0.1% | 18K | — | |||
| 111 | — | Team Health Holdings Inc. - COM | — | $658 | 0.1% | 15K | — | |||
| 112 | $MYGN | MYRIAD GENETICS INC | Healthcare | $604 | 0.1% | 14K | -58% | |||
| 113 | $ABUS | Arbutus Biopharma Corp | Healthcare | $556 | 0.1% | 125K | — | |||
| 114 | — | Juniper Pharmaceuticals Inc. - COM | — | $515 | 0.1% | 50K | — | |||
| 115 | — | Cadiovascular Systems Inc. - COM | — | $454 | 0.1% | 30K | — | |||
| 116 | — | MannKind Corporation - COM | — | $435 | 0.1% | 300K | — | |||
| 117 | — | Immunomedics, Inc. - COM | — | $407 | 0.1% | 30K | — | |||
| 118 | — | Endocyte, Inc. - COM | — | $401 | 0.1% | 100K | -37% | |||
| 119 | $THC | TENET HEALTHCARE CORP | Healthcare | $303 | 0.1% | 10K | -92% | |||
| 120 | — | XOMA Corporation - COM | — | $299 | 0.1% | 225K | — | |||
| 121 | — | Heartware International, Inc. - COM | — | $252 | 0.0% | 5,000 | -89% | |||
| 122 | — | Tetraphase Pharmaceuticals, Inc. - COM | — | $221 | 0.0% | 22K | — | |||
| 123 | $GERN | GERON CORP | Healthcare | $218 | 0.0% | 45K | — | |||
| 124 | $TBPH | Theravance Biopharma, Inc. | Healthcare | $187 | 0.0% | 11K | — | |||
| 125 | — | Celladon Corporation - COM | — | $74 | 0.0% | 50K | — | |||
| 126 | — | Asterias Biotherapeutics, Inc. - COM SER A | — | $7 | 0.0% | 1,875 | — | |||
| 127 | — | Biotime Inc. - W EXP 10/01/2018 | — | $3 | 0.0% | 2,294 | New |
What changed in Q4 2015
Against the previous quarter's 13F: 9 new, 39 added to, 25 trimmed, 15 sold out. Share-count changes; largest moves by dollar size first.
New positions (9)
$IONSIONIS PHARMACEUTICALS INC$9K
first bought this quarter
$EGBNEAGLE BANCORP INC$5K
first bought this quarter
- Lannett Inc. - COM$4K
first bought this quarter
- Radius Health Inc. - COM NEW$2K
first bought this quarter
- Zeltiq Aesthetics Inc. - COM$2K
first bought this quarter
$PTCTPTC THERAPEUTICS, INC.$2K
first bought this quarter
+3 more in the Excel export
Added to (39)
$CAHCARDINAL HEALTH INC+114%
now $15K · held 4+ qtrs
$CNCCENTENE CORP+428%
now $7K · held 4+ qtrs, 2 adds in a row
- Mylan Inc. - COM+40%
now $17K
$CVSCVS HEALTH Corp+75%
now $9K · held 4+ qtrs, 3 adds in a row
$BIIBBIOGEN INC.+17%
now $26K · held 4+ qtrs
$BAXBAXTER INTERNATIONAL INC+120%
now $4K · held 2 qtrs, 2 adds in a row
+33 more in the Excel export
Trimmed (25)
- Kite Pharma, Inc. - COM-88%
now $863
$ABTABBOTT LABORATORIES-18%
now $17K · held 4+ qtrs
$THCTENET HEALTHCARE CORP-92%
now $303 · held 4+ qtrs
- Express Scripts Holding Company - COM-23%
now $11K
- Heartware International, Inc. - COM-89%
now $252
$VRTXVERTEX PHARMACEUTICALS INC / MA-19%
now $8K · held 4+ qtrs, 3 trims in a row
+19 more in the Excel export
Holdings by quarter
Every 13F Bellevue Asset Management AG has filed, 3 earlier quarters. Pick one to see what it held then.
Is it too late to follow Bellevue Asset Management AG?
Holdings as of Dec 31, 2015 (SEC filing). Prices are closing prices as of Nov 19, 2026.
Average quality of Bellevue Asset Management AG's top 20 holdings: 62/100 (our AI quality score, weighted by position size; 18 of the 20 are scored)
Top 10 since quarter-end
—
Value-weighted move of the 10 largest stock positions
Turnover
12%
Last quarter
Top 10 weight
31%
Share of the stock portfolio in its 10 largest positions
Held 4+ quarters
93%
Share of portfolio value in positions held a year or more
Highest-quality names it owns(among its 100 largest positions)
The 8 highest-scoring companies in this portfolio are a Pro feature.
How these are measured
- Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
- Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
- Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2015 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
- Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
- Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.
Portfolio Overview
Bellevue Asset Management AG disclosed 127 positions worth $656,313 in its Form 13F-HR for Q4 2015, followed by $BIIB and $GILD. During the quarter the fund opened 9 new positions and exited 15 — including a new stake in $IONS. The portfolio is most concentrated in Healthcare (65.7% of disclosed assets). All figures are sourced directly from Bellevue Asset Management AG’s Form 13F-HR filing with the SEC under CIK 1642343.
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: Bellevue Asset Management AG
13F Pro is an AI hedge fund tracker and stock research platform. For Bellevue Asset Management AG (SEC CIK: 1642343), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Bellevue Asset Management AG's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.